Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

 

2019 ASH Review on Venetoclax in the R/R CLL: With Additional Follow Up, Is This Regimen Holding up to the Promise of a Time Limited Therapy With Durable Remissions?

April 14, 2020

0 Comments
Login to view comments. Click here to Login
Leukemia